Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-23-020064
Filing Date
2023-07-05
Accepted
2023-07-05 16:24:14
Documents
1
Period of Report
2023-07-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3202
  Complete submission text file 0001127602-23-020064.txt   4653
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Issuer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
WIERENGA WENDALL (Reporting) CIK: 0001235945 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50633 | Film No.: 231069435